{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T21:27:19Z","timestamp":1726176439902},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DMSO"],"DOI":"10.2147\/dmso.s32018","type":"journal-article","created":{"date-parts":[[2012,5,28]],"date-time":"2012-05-28T04:27:21Z","timestamp":1338179241000},"page":"125","source":"Crossref","is-referenced-by-count":5,"title":["Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients"],"prefix":"10.2147","author":[{"given":"Harold","family":"Bays","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,5]]},"container-title":["Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=12822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:15:39Z","timestamp":1477865739000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/long-term-52ndash78-weeks-treatment-with-colesevelam-hcl-added-to-metf-peer-reviewed-article-DMSO"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dmso.s32018","relation":{},"ISSN":["1178-7007"],"issn-type":[{"value":"1178-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}